info@p-95.com

OUR papers

scientific publications

At P95, we are at the forefront of public health innovation, driving impactful research and delivering tailored solutions. Our publications are a testament to our expertise in vaccines and infectious diseases for clinical trials, epidemiology and real-world evidence. Explore our latest insights and groundbreaking studies below, and discover how we are making a difference to global health.

COVIDRIVE: AZD1222 vaccine effectiveness against hospitalisation

COVIDRIVE: AZD1222 vaccine effectiveness against hospitalisation

Vaccine effectiveness (VE) studies with long-term follow-up are needed to understand durability of protection against severe COVID-19 outcomes conferred by primary-series vaccination in individuals not receiving boosters. COVIDRIVE is a European public-private partnership evaluating brand-specific vaccine effectiveness (VE). We report a prespecified interim analysis of primary-series AZD1222 (ChAdOx1 nCoV-19) VE.

read more
Lyme Disease Publications

Lyme Disease Publications

P95 has collaborated in a large review study about Lyme disease. This study has involved databases/surveillance and systematic reviews focusing on Lyme disease incidence, epidemiology, hospitalization, and clinical manifestations, among other outcomes, in different regions of the World.

read more